Angiotensin Receptor Antagonists
Showing 1 - 25 of 9,435
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)
Not yet recruiting
- Breast Cancer
- +12 more
-
Opole, Opolskie, Poland
- +3 more
Jul 15, 2022
STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- Left Ventricular Systolic Dysfunction
- Dapagliflozin 10Mg Tab
- Placebo
- (no location specified)
Sep 6, 2021
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)
Recruiting
- Aortic Stenosis
- Angiotensin Receptor Blockers
- Placebo
-
Québec, Quebec, Canada
- +1 more
Mar 28, 2022
Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)
Not yet recruiting
- Breast Cancer
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +2 more
-
Hanzhou, Zhejiang, Chinathe Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023
Primary Aldosteronism Trial in Montréal (Renin measurements)
Not yet recruiting
- Primary Aldosteronism
- Renin measurements
-
Montréal, Quebec, CanadaHôpital du Sacré-Coeur de Montréal
Oct 30, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Interleukin 6 Receptor Antagonists in Corona Virus Disease 19
Recruiting
- Corona Virus Infection
- ELISA
-
Assiut, EgyptAssiutU
Feb 2, 2023
Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)
Not yet recruiting
- Pediatric Cancer
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
May 23, 2023
Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical
Not yet recruiting
- Primary Hyperaldosteronism Due to Adrenal Adenoma
- Unilateral adrenalectomy
- Medical treatment (eplerenone)
-
Gothenburg, Sweden
- +2 more
Mar 30, 2023
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)
Recruiting
- Alcohol Use Disorder
- Suvorexant
- Placebo
-
Columbus, OhioThe Ohio State University
Dec 11, 2022
IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.
Withdrawn
- Critical Illness Sepsis, Severe
- (no location specified)
Jun 13, 2022
Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)
Not yet recruiting
- Coarctation of Aorta
- High Blood Pressure
- Losartan
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Coronavirus Disease 2019 Patients Receiving Receiving
Completed
- COVID-19
- Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
Aug 1, 2020
IL-1ß and Its Receptor Antagonists in Treatment of Severe
Withdrawn
- Critical Illness
- Sepsis, Severe
- (no location specified)
Jun 13, 2022
Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)
Completed
- Coronavirus Disease 2019
- COVID-19
- Angiotensin Receptor Blockers
- Placebo
-
Camperdown, New South Wales, Australia
- +21 more
Mar 2, 2022
s to Learn More About Treatment With Steroidal Mineralocorticoid
Active, not recruiting
- Chronic Kidney Disease
- +2 more
- sMRA therapies
-
Whippany, New JerseyMany Locations
Jan 30, 2023
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023